Article
Organometallics, Vol. 29, No. 14, 2010 3157
2
2
1.21 (vt, 2JH-P = 4JH-P = 2.7 Hz, 18H, mutually trans-PMe3),
1.32 (d, 2JH-P = 6.6 Hz, 9H, PMe3), 1.40 (d, 2JH-P = 5.1 Hz,
(dt, JP-P = 86, JP-P = 39 Hz, 1P, P(OMe)3 trans to CH2),
156.8 (dt, 2JP-P = 86, 2JP-P = 43 Hz, 1P, P(OMe)3 trans to S).
Treatment of 2d with PMe2Ph. Complex 2d (7.0 mg, 0.012
mmol) was placed in an NMR tube into which C6D6 (0.6 mL)
was introduced by vacuum distillation. Then PMe2Ph (1.6 μL,
0.011 mmol) was added into the NMR tube by a hypodermic
syringe. The reaction system was monitored at 30 °C for 16.5 h
by NMR, then tripheylmethane (4.4 mg, 0.018 mmol) was added
to the reaction mixture as an internal standard. The conversion
of 2d was 99%, and unidentified products were formed in which
a 4:6 mixture of (OC-6-34)-Ru[SC6H3(CH2-2)(Me-6)-κ2S,C]-
(PMe3)3(PMe2Ph) (OC-6-34)-1g and (OC-6-24)-1g was pro-
duced in 31% yield with concomitant formation of 2,6-dim-
3
9H, PMe3), 2.37 (s. 3H, SC6H3Me), 2.47 (tt, JH-P = 12.6,
3JH-P = 4.5 Hz, 2H, SC6H3CH2), 6.89 (br. t, 3JH-H = 7 Hz, 1H,
SC6H3), 7.03 (br d, 3JH-H = 7 Hz, 2H, SC6H3). 31P{1H} NMR
(122 MHz, CDCl3, 24 °C) δ -16.26 (td, 2JP-P = 31, 2JP-P = 18
2
Hz, 1P, PMe3, trans to CH2), -7.72 (t, JP-P = 31 Hz, 2P,
mutually trans-PMe3), 1.53 (td, 2JP-P = 31, 2JP-P = 18 Hz, 1P,
PMe3 trans to S). 2d: 1H NMR (300 MHz, CDCl3, 23 °C) δ 1.51
(m, 27H, PMe3), 2.22 (s, 12H, SC6H3Me2), 6.71 (t, JH-H =
3
7 Hz, 1H, SC6H3Me2), 6.98 (d, 2JH-H = 7 Hz, 2H, SC6H3Me2).
1
31P{1H} NMR (122 MHz, CDCl3, 24 °C) δ 17.69 (s). 3d: H
NMR (300 MHz, CDCl3, 30 °C) δ 1.46 (br.m, 18H, PMe3), 1.52
1
2
4
ethylbenzenethiol in 36% yield. (OC-6-34)-1g: H (300 MHz,
C6D6, 19 °C) δ 0.98-1.12 (m, overlapped, PMe3 and PMe2Ph),
(s, 6H, ortho-Me), 1.59 (vt, JH-P = JH-P = 3.3 Hz, 18H,
PMe3), 2.35 (overlapped with ortho-Me groups in free 2,6-
dimethylbenzenethiol, ortho-Me), 6.57 (t, JH-H = 7 Hz, 1H,
3
3
3
2.75 (tt, JH-P = 13.5, JH-P = 4.5 Hz, 2H, SC6H3CH2), 2.9
(overlapped with ortho Me in (OC-6-24)-1g, SC6H3Me), 6.9-
7.25 (overlapped with other aromatic protons, SC6H3 and
PMe2Ph). 7.3-7.4 (overlapped with other aromatic protons,
3
para-C6H3Me2), 6.68 (d, JH-H = 7 Hz, 1H, para-C6H3Me2),
6.8-7.0 overlapped with aromatic protons. 31P{1H} NMR (122
MHz, CDCl3, 24 °C) δ -9.77 (t, 2JP-P = 33 Hz, 2P, mutually
trans PMe3), 12.08 (t, 2JH-H = 33 Hz, 2P, PMe3 trans to S).
Treatment of 2d with PMe3 in Dichloromethane-d2. Complex
2d (5.1 mg, 0.0084 mmol) was placed in an NMR tube into which
CD2Cl2 (0.6 mL) was introduced by vacuum distillation. Tri-
phenylmethane (2.9 mg, 0.012 mmol) was added as an internal
standard and then PMe3 (2.3 μL, 0.022 mmol) was added by a
hypodermic syringe. The reaction was monitored at 30 °C by
NMR. After 10 min, 1d (0.0013 mmol, 15%) and 3d (0.0058
PMe2Ph). 31P{1H} NMR (122 MHz, C6D6) δ -16.7 (td, 2JP-P
28, 2JP-P = 19 Hz, 1P, PMe2Ph trans to CH2), -8.32 (t, 2JP-P
=
=
28 Hz, 2P, mutually trans PMe3), 0.16 (td, 2JP-P = 28, 19 Hz, 1P,
PMe3 trans to S). (OC-6-24)-1g: 1H (300 MHz, C6D6, 19 °C) δ
0.98-1.12 (m, overlapped, PMe3 and PMe2Ph), 2.9 (overlapped
3
with ortho Me in (OC-6-34)-1g, SC6H3Me), 3.11 (tt, JH-P
=
3
13.5, JH-P =4.5 Hz, 2H, SC6H3CH2), 6.9-7.25 (overlapped
with other aromatic protons, SC6H3 and PMe2Ph). 7.3-7.4
(overlapped with other aromatic protons, PMe2Ph). 31P{1H}
NMR (122 MHz, C6D6) δ -17.60 (td, 2JP-P = 28, 2JP-P = 19
1
mmol, 69%) were observed in 90% conversion of 2d. 1d: H
=
NMR (300 MHz, CD2Cl2, 19 °C) δ 1.19 (vt, 2JH-P = 4JH-P
2.7 Hz, 18H, mutually trans-PMe3), 1.34 (d, JH-P = 7.5 Hz,
2
2
Hz, 1P, PMe3 trans to CH2), -9.62 (t, JP-P = 28 Hz, 2P,
mutually trans PMe3), 9.35 (td, 2JP-P = 28, 19 Hz, 1P, PMe2Ph
trans to S).
2
9H, PMe3), 1.39 (d, JH-P = 5.7 Hz, 9H, PMe3), 2.28 (s. 3H,
SC6H3Me), 2.45-2.50 (m, 2H, SC6H3CH2), 6.9-7.0 (m, over-
lapped with other aromatic signals, SC6H3). 31P{1H} NMR (122
MHz, CD2Cl2, 19 °C) δ -16.3 (td, 2JP-P = 31, 2JP-P = 18 Hz,
1P, PMe3, trans to CH2), -7.9 (t, 2JP-P = 31 Hz, 2P, mutually
Treatment of 2d with CO. Complex 3h (17.6 mg, 0.0259 mmol)
was placed in a Schlenk tube into which benzene (5 mL) was
added. After cooling of the reaction mixture with liquid nitro-
gen, the reaction system was evacuated. Carbon monoxide
(0.1 MPa) was then introduced to the Schlenk tube. Right after
exposure of 2d to CO, the red solution turned to yellow. After
10 min, all volatile matters were removed under reduced pres-
sure to give yellow powder, which was repeatedly washed with
hexane. After drying of the resulting yellow powder under
reduced pressure, cis,cis,cis-Ru(SC6H3Me2-2,6)2(PMe3)2(CO)2
(cis,cis,cis-3h) was obtained in 93% yield (12.5 mg, 0.024 mmol).
At 50 °C in benzene, 3h constitutes an equilibrium mixture
between cis,cis,cis-3h and trans,trans,trans-3h (Keq = [trans,
2
2
trans-PMe3), 1.5 (td, JP-P=31, JP-P = 18 Hz, 1P, PMe3
trans to S). 3d: 1H NMR (300 MHz, CD2Cl2, 30 °C) δ 1.45 (m,
2
4
18H, PMe3), 1.52 (vt, JH-P = JH-P = 3.3 Hz, 18H, PMe3),
2.56 (s, 12H, SC6H3Me2), 7.14-7.23 (m, 6H, SC6H3Me2). 31P-
{1H} (122 MHz, CD2Cl2, 30 °C) δ -10.01 (t, 2JP-P = 33 Hz, 2P,
mutually trans PMe3), 11.62 (t, 2JH-H = 33 Hz, 2P, PMe3 trans
to S).
Treatment of 2d with H2O. Complex 2d (9.7 mmol, 0.014
mmol) was placed in a NMR tube into which C6D6 (600 μL) was
introduced by vacuum transfer. 1,4-Dioxane (1.4 μL, 0.16
mmol) was added as an internal standard. Degassed deionized
water (5.0 μL, 0.28 mmol) was added by a hypodermic syringe.
After 3 days at room temperature, cis,mer-Ru(SC6H3Me2-2,6)2-
1
trans,trans-3h][cis,cis,cis-3h] = 9.9 at 50 °C). cis,cis,cis-3h: H
NMR (300 MHz, C6D6) δ 0.95 (d, 2JH-P = 9 Hz, 9H, PMe3),
1.31 (d, JH-P = 9 Hz, 9H, PMe3), 2.54 (s, 6H, ortho-
2
1
(PMe3)3(OH2) (3e) was produced in 62% yield. 3e: H NMR
(300 MHz, C6D6) δ 1.12-1.15 (m, 9H, PMe3 trans to S), 1.20 (vt,
=
SC6H3Me2), 2.90 (s, 6H, ortho-SC6H3Me2), 6.96 (t, 3JH-H = 7 Hz,
1H, para-SC6H3Me2), 7.08 (t, JH-H = 7 Hz, 1H, para-
3
3
SC6H3Me2), 7.12 (d, JH-H = 7 Hz, 2H, meta-SC6H3Me2),
2JH-P
4JH-P = 2.7 Hz, 18H, mutually trans-PMe3),
2.45-2.50 (br s, 12H, SC6H3Me2), 6.95 (t, 3JH-H = 7 Hz, 2H,
SC6H3Me2), 7.03 (br d, JH-H = 7 Hz, 4H, SC6H3Me2), 11.5
7.26 (d, JH-H =7 Hz, 2H, meta-SC6H3Me2). 31P{1H} (122
3
MHz, C6D6) δ -16.09 (d, 2JP-P = 35 Hz, 1P, PMe3), -11.46 (d,
2JP-P = 35 Hz, 1P, PMe3). IR (KBr, cm-1) 3041(w), 2963(w),
2913(w), 2036(s). 1973(vs), 1458(w), 1424(w), 1365(w), 1312(w),
1291(w), 1160(w), 1054(w), 960(m), 946(m), 849(w), 763(m),
740(w), 719(w), 585(w), 561(m). Anal. Calcd for C24H36O2-
P2RuS2: C, 49.39; H, 6.22%. Found: C, 49.38; H, 6.75%.
trans,trans,trans-3h: 1H NMR (300 MHz, C6D6) δ 1.08 (vt,
3
(br, 2H, OH2). 31P{1H} NMR (122 MHz, C6D6) δ -3.58 (d,
=
2JP-P = 36 Hz, 2P, mutually trans PMe2), 39.68 (t, JP-P
36 Hz, 1P, PMe3 trans to S).
2
Treatment of 2d with P(OMe)3. Complex 2d (5.6 mg, 0.0093
mmol) was placed in an NMR tube into which triphenylmethane
(5.5 mg, 0.0225 mmol) was added as an internal standard.
Trimethylphosphite (1.2 μL, 0.01 mmol) was added into the
solution. After 10 min at room temperature, 2d was completely
converted into cis,trans,cis-Ru[SC6H3(CH2-2)(Me-6)-κ2S,C]-
(PMe3)2[P(OMe)3]2 (1f) in 100% yield. Complex 1f was char-
2JH-P = JH-P = 3.7 Hz, 18H, mutually trans PMe3), 2.89 (s,
4
12H, SC6H3Me2), 6.96 (t, 3JH-H = 7 Hz, 2H, para-SC6H3Me2),
7.07 (d, JH-H = 7 Hz, 4H, meta-SC6H3Me2). 31P{1H} NMR
3
(122 MHz, C6D6) δ -14.81 (s).
1
acterized by spectroscopic methods. 1f: H NMR (300 MHz,
C6D6) δ 1.47 (vt, 2JH-P = 4JH-P = 4 Hz, 18H, mutually trans
PMe3), 1.86 (s, 3H, C6H3Me), 2.5 (br, 2H, C6H3CH2), 3.27 (d,
Treatment of 2a with PMe3. Complex 2a (324.5 mg, 0.4030
mmol) was dissolved in a THF solution (16 mL) into which
PMe3 (120 μL, 1.16 mmol) was added by use of a hypodermic
syringe. The reaction mixture was warmed at 50 °C for 2 days.
Then, all volatile matters were removed under reduced pressure
and the resulting solid was dissolved with acetone. Hexane was
added into the acetone solution to deposit unreacted 2a. The
3
3JH-P = 11 Hz, 9H, P(OMe)3), 3.33 (d, JH-P = 10 Hz, 9H,
P(OMe)3), 7.0-7.2 (partly overlapped with undeuterated ben-
zene in C6D6, C6H3). 31P{1H} NMR (122 MHz, C6D6) δ 3.5 (dd,
2
2JP-P = 43, JP-P = 39 Hz, 2P, mutually trans-PMe3), 100.7